Technology’s Role In Advancing Outcomes & Reducing The Cost Of Care For The SMI Population is starting in

Medicare Program Final Rule; Medicare Clinical Diagnostic Laboratory Tests Payment System

On June 23, 2016, the federal Department of Health and Human Services released this final rule implementing requirements of section 216 of the Protecting Access to Medicare Act of 2014 (PAMA), which significantly revises the Medicare payment system for clinical diagnostic laboratory tests. Under the final rule, clinical diagnostic tests will be reimbursed at the weighted median of private payer rates determined for that specific test. The new reimbursement rates will go into effect January 1, 2018 . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.